Home

Thursday, May 24, 2018 - 13:52
The ingredients and science behind growth factor-based topicals.By Inga HansenGrowth factor-BASED serums and creams have become ubiquitous in topical antiaging skin care. But what these different products contain can vary widely. Some products contain actual growth factors—either animal- or plant-derived—and others use so-called “signaling” ingredients, typically peptides that trigger the cells in a manner similar to naturally occurring growth factors. In all cases, the goal is to combat the changes that occur in aging skin
https://www.medestheticsmag.com/restoring-growth
Thursday, May 24, 2018 - 13:52
The ingredients and science behind growth factor-based topicals.By Inga HansenGrowth factor-BASED serums and creams have become ubiquitous in topical antiaging skin care. But what these different products contain can vary widely. Some products contain actual growth factors—either animal- or plant-derived—and others use so-called “signaling” ingredients, typically peptides that trigger the cells in a manner similar to naturally occurring growth factors. In all cases, the goal is to combat the changes that occur in aging skin
https://www.medestheticsmag.com/restoring-growth
Thursday, May 24, 2018 - 13:36
The U.S. Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft (Nestlé Skin Health) for the correction of age-related volume loss in the back of the hands for patients over the age of 21. It is the first HA injectable gel to be FDA-approved for restoring fullness to the back of the hands.
https://www.medestheticsmag.com/restylane-lyft-approved-hands

Advertisement - Box 1

Advertisement - Box 2

Thursday, May 24, 2018 - 13:36
The U.S. Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft (Nestlé Skin Health) for the correction of age-related volume loss in the back of the hands for patients over the age of 21. It is the first HA injectable gel to be FDA-approved for restoring fullness to the back of the hands.
https://www.medestheticsmag.com/restylane-lyft-approved-hands
Thursday, May 24, 2018 - 13:32
Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercialization of its daxibotulinumtoxinA injectable (RT002) for the treatment of glabellar lines.
https://www.medestheticsmag.com/revance-gears-launch-rt002-neurotoxin
Thursday, May 24, 2018 - 13:32
Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercialization of its daxibotulinumtoxinA injectable (RT002) for the treatment of glabellar lines.
https://www.medestheticsmag.com/revance-gears-launch-rt002-neurotoxin

Advertisement - Box 3

Advertisement - Box 4

Thursday, May 10, 2018 - 12:54
The Aesthetic Surgery Journal (ASJ) in conjunction with Oxford University Press will begin publishing an open access publication (a restriction- and subscription-free online research journal), titled Aesthetic Surgery Journal Open Forum in January 2019.
https://www.medestheticsmag.com/aesthetic-surgery-journal-launch-open-access-publication
Thursday, May 10, 2018 - 12:54
The Aesthetic Surgery Journal (ASJ) in conjunction with Oxford University Press will begin publishing an open access publication (a restriction- and subscription-free online research journal), titled Aesthetic Surgery Journal Open Forum in January 2019.
https://www.medestheticsmag.com/aesthetic-surgery-journal-launch-open-access-publication
Thursday, May 10, 2018 - 10:17
More than ever, consumers across the globe are demanding skincare products that are not only effective, but organic and naturally sourced, too.
https://www.beautystorebusiness.com/skincare-market-reach-17715-billion-2024

Pages

Advertisement - Box 5

Advertisement - Box 6